Palo Alto Investors LP Gritstone Bio, Inc. Transaction History

Palo Alto Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.17 - $3.92 $3.61 Million - $6.52 Million	-1,664,377 Reduced 71.42%	666,127 $2.3 Million
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $103,885 - $314,233	-25,778 Reduced 1.09%	2,330,504 $9.6 Million
Q2 2021 Aug 16, 2021	BUY	$8.13 - $10.2 $470,727 - $590,580	57,900 Added 2.52%	2,356,282 $21.5 Million
Q1 2021 May 17, 2021	BUY	$4.07 - $27.11 $9.35 Million - $62.3 Million	2,298,382 New	2,298,382 $21.7 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

Stay updated on Palo Alto Investors LP with notifications on news.